Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Sarah S Tonkin"'
Autor:
Adam C Ferkin, Sarah S Tonkin, Eugene Maguin, Martin C Mahoney, Craig R Colder, Stephen T Tiffany, Larry W Hawk
Publikováno v:
Nicotine & Tobacco Research. 24:1914-1920
Introduction Although treatment outcome expectancies (TOEs) may influence clinical outcomes, TOEs are rarely reported in the smoking cessation literature, in part because of the lack of validated measures. Therefore, we conducted a psychometric evalu
Types of Traumatic Experiences in Drug Overdose-Related Deaths: An Exploratory Latent Class Analysis
Autor:
Judy H. Hong, Constanza de Dios, Jessica C. Badawi, Sarah S. Tonkin, Joy M. Schmitz, Consuelo Walss-Bass, Thomas D. Meyer
Publikováno v:
medRxiv
AimDrug overdose related-deaths in the US are increasing, with over 100,000 deaths occurring in 2020, an increase of 30% from the previous year and the highest number recorded in a single year. It is widely known that experiences of trauma and substa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0c4b2792008d0baaa45dc268170b16
https://doi.org/10.1101/2023.04.30.23289256
https://doi.org/10.1101/2023.04.30.23289256
Autor:
Schuyler C. Lawson, Sarah S. Tonkin, Robert K. Cooper, Jennifer L. Temple, Larry W. Hawk, Amanda M. Ziegler
Publikováno v:
Experimental and Clinical Psychopharmacology. 29:82-89
Despite the growing interest in caffeine use and its effects among adolescents, and a large literature on caffeine and attention among adults, there is a lack of experimental work examining the impact of caffeine on sustained attention among adolesce
Autor:
Sarah S Tonkin, Craig Colder, Martin C Mahoney, Gary E Swan, Paul Cinciripini, Robert Schnoll, Tony P George, Rachel F Tyndale, Larry W Hawk
Publikováno v:
Nicotine Tob Res
Introduction Negative reinforcement models posit that relapse to cigarette smoking is driven in part by changes in affect and craving during the quit attempt. Varenicline may aid cessation by attenuating these changes; however, this mediational pathw
Autor:
Schuyler C. Lawson, Martin C. Mahoney, Robert K. Cooper, Sarah S. Tonkin, Craig R. Colder, Stephen T. Tiffany, Larry W. Hawk, Julie C. Gass
Publikováno v:
Psychopharmacology (Berl)
RATIONALE: Varenicline, a partial nicotinic agonist, is theorized to attenuate pre-quit smoking reinforcement and post-quit withdrawal and craving. However, the mechanisms of action have not been fully characterized, as most studies employ only retro
Autor:
Larry W. Hawk, Trevor F. Williams, Stephen T. Tiffany, Sarah S. Tonkin, Leonard J. Simms, Paul M. Cinciripini, Martin C. Mahoney, Robert A. Schnoll
Publikováno v:
Nicotine & Tobacco Research. 22:482-491
Introduction Assessment of withdrawal symptoms, treatment mechanisms, and side effects is central to understanding and improving smoking cessation interventions. Though each domain is typically assessed separately with widely used questionnaires to s
Autor:
Larry W. Hawk, Sarah S. Tonkin
Publikováno v:
Behavioural processes. 178
Research suggests that repetitive reinforcers wane in their ability to maintain operant behavior in a manner consistent with habituation. Weaker reinforcers, including sensory stimuli common in human work, may be most impacted by repetition. The pres
Autor:
Lazzarino R; Nuffield Department of Primary Care Health Sciences, Medical Division, University of Oxford, Oxford, United Kingdom., Borek AJ; Nuffield Department of Primary Care Health Sciences, Medical Division, University of Oxford, Oxford, United Kingdom.; National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, United Kingdom., Honeyford K; Team Health Informatics, Institute of Cancer Research, London, United Kingdom., Welch J; University College Hospital, London, United Kingdom., Brent AJ; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Kinderlerer A; Imperial College Healthcare NHS Trust, London, United Kingdom., Cooke G; Imperial College Healthcare NHS Trust, London, United Kingdom., Patil S; Chelsea and Westminster Hospital, London, United Kingdom., Gordon A; Imperial College Healthcare NHS Trust, London, United Kingdom., Glampson B; Imperial College Healthcare NHS Trust, London, United Kingdom., Goodman P; PPI representative, Oxford, United Kingdom., Ghazal P; School of Medicine, Cardiff University, Cardiff, United Kingdom., Daniels R; UK Sepsis Trust and Global Sepsis Alliance, Birmingham, United Kingdom., Costelloe CE; Team Health Informatics, Institute of Cancer Research, London, United Kingdom., Tonkin-Crine S; Nuffield Department of Primary Care Health Sciences, Medical Division, University of Oxford, Oxford, United Kingdom.; National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, United Kingdom.
Publikováno v:
JMIR human factors [JMIR Hum Factors] 2024 Oct 15; Vol. 11, pp. e56949. Date of Electronic Publication: 2024 Oct 15.
Autor:
Mcleod M; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.; NIHR Imperial Patient Safety Translational Research Centre, Imperial College London, London, UK., Campbell A; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK., Hayhoe B; Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.; NIHR Applied Research Collaboration Northwest London, London, UK., Borek AJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Tonkin-Crine S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK., Moore MV; Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Walker AS; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Holmes A; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK., Wong G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. geoffrey.wong@phc.ox.ac.uk.
Publikováno v:
BMC public health [BMC Public Health] 2024 Oct 14; Vol. 24 (1), pp. 2820. Date of Electronic Publication: 2024 Oct 14.
Autor:
Hoste ME; Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Borek AJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; National Institute for Health and Care Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK., Santillo M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Roberts N; Bodleian Health Care Libraries, University of Oxford, Oxford, UK., Tonkin-Crine S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; National Institute for Health and Care Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK., Anthierens S; Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.